Aurobindo Pharma shareholders and shareholding pattern
NSE: AUROPHARMABSE: 524804Pharmaceuticals & BiotechnologyMid Cap
Share price at the NSE close on 27 Oct 2026. Previous close ₹1,590.00.
27 Oct: open ₹1,600.00, high ₹1,635.00, low ₹1,597.20
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹93,643 Cr138th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 25.22
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.47
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 11,64,93260.5% delivered
Aurobindo Pharma's shareholding pattern for Sep 2026, filed on 14 Oct 2026, with every filing from Dec 2016: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Aurobindo Pharma, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters51.88%
- Foreign institutions17.41%
- Indian institutions24.42%
- GovernmentsNone
- Individuals and others6.29%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Governments
- Individuals and others
| Per cent | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.94% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 52.01% | 52.01% | 52.01% | 51.94% | 51.94% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.80% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.88% | 51.88% | |
| Indian promoters | 48.86% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.94% | 48.94% | 48.94% | 48.86% | 48.86% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.73% | 48.75% | 48.75% | 48.75% | 48.75% | 48.75% | 48.75% | 48.75% | 48.81% | 48.80% |
| Foreign promoters | 3.08% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 48.06% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 47.99% | 47.99% | 47.99% | 48.06% | 48.06% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.20% | 48.18% | 48.18% | 48.18% | 48.18% | 48.18% | 48.18% | 48.18% | 48.12% | 48.12% |
| Promoter shares pledgedShare of the promoters' own shares | 1.40% | 1.27% | 1.22% | 1.53% | 1.79% | 2.01% | 2.09% | 2.21% | 2.30% | 3.49% | 3.82% | 4.20% | 4.99% | 6.17% | 6.17% | 9.34% | 9.27% | 22.81% | 20.66% | 22.98% | 22.97% | 14.05% | 14.97% | 14.92% | 16.15% | 17.90% | 19.16% | 19.56% | 18.90% | 20.86% | 20.88% | 20.39% | 17.83% | 16.92% | 17.08% | 17.50% | 17.50% | 23.65% | 13.75% | 11.99% |
| Shares in issue | 58,51,69,586 | 58,58,82,409 | 58,58,82,409 | 58,58,82,409 | 58,58,82,409 | 58,59,07,609 | 58,59,07,609 | 58,59,07,609 | 58,59,07,609 | 58,59,15,609 | 58,59,15,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,08,01,623 | 58,08,01,623 | 58,08,01,623 | 58,08,01,623 | 58,08,01,623 | 58,08,01,623 | 58,08,01,623 | 57,53,77,895 | 57,53,77,895 |
Aurobindo Pharma promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is RPR SONS ADVISORS PRIVATE LIMITED, MRS.P.SUNEELA RANI (JOINTLY HOLDING), 33.54%. The filing names 1 more member with no shares.Promoter buying and selling
| Holder | |||
|---|---|---|---|
| RPR SONS ADVISORS PRIVATE LIMITED, MRS.P.SUNEELA RANI (JOINTLY HOLDING)Indian companies, trusts and others | 33.54% | 19,29,97,923 | 10.95% |
| KAMBAM NITHYANANDA REDDYIndividuals and Hindu undivided families | 4.37% | 2,51,48,052 | 41.55% |
| KIRTHI REDDY KAMBAMIndividuals and Hindu undivided families | 3.46% | 1,99,01,635 | 13.57% |
| VENKATA RAMPRASAD REDDY PENAKANon-resident and foreign individuals | 3.07% | 1,76,90,341 | 0.00% |
| AXIS CLINICALS LIMITED, TRIDENT CHEMPHAR LIMITED, RPR SONS ADVISORS PVT.LTD. (JOINTLY HOLDING)Indian companies, trusts and others | 2.86% | 1,64,38,963 | 0.00% |
| MEENAKSHISUNDERAM SIVAKUMARANIndividuals and Hindu undivided families | 2.48% | 1,42,42,061 | 0.00% |
| KAMBAM SPOORTHIIndividuals and Hindu undivided families | 1.20% | 68,83,414 | 5.81% |
| KOTTAMANCHI RAJESWARIIndividuals and Hindu undivided families | 0.31% | 17,94,100 | 11.15% |
| M SUMANTH KUMAR REDDYIndividuals and Hindu undivided families | 0.27% | 15,72,477 | 50.88% |
| TRIDENT CHEMPHAR LIMITEDIndian companies, trusts and others | 0.13% | 7,75,957 | 0.00% |
| AXIS CLINICALS LIMITEDIndian companies, trusts and others | 0.11% | 6,46,682 | 0.00% |
| PRASADA REDDY KAMBHAMIndividuals and Hindu undivided families | 0.05% | 2,70,976 | 36.90% |
Largest public holders of Aurobindo Pharma, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Aurobindo Pharma
| Holder | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LIFE INSURANCE CORPORATION OF INDIAInsurance companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.91% | 3.46% | 4.34% | 5.33% | 5.48% | 5.48% | 5.48% | 5.57% | 5.57% | 5.55% | 5.43% | 3.81% | 3.38% | 2.78% | 2.08% | 2.08% | 2.45% | 2.49% | 2.91% | 2.91% | 2.93% | 2.94% | 2.85% |
| NPS TRUST A/C - SBI PENSION FUND - UPS - CG SCHEMProvident and pension funds | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.23% | – | – | 2.80% |
| NPS TRUST - A/C SBI PENSION FUND SCHEME - NPS TIERProvident and pension funds | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.74% | – |
| NPS TRUST- A/C ICICI PRUDENTIAL PENSION FUND SCHEMProvident and pension funds | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.57% | 1.92% | 2.20% | 2.10% | 2.11% | – | 2.34% | In concert | – |
| BNP PARIBAS FINANCIAL MARKETSForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.62% | – | – | – | – | – | – | – | – | – | – | – |
| BNP PARIBAS ARBITRAGEForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.07% | 1.04% | 1.08% | 1.21% | In concert | 1.22% | 1.22% | 1.15% | 1.19% | 1.12% | 1.19% | 1.22% | In concert | 1.24% | 1.41% | – | – | – | – | – | – | – | – | – | – | – | – |
| INVESCO ASIAN EQUITY INCOME FUND (UK)Foreign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | In concert | In concert | 1.12% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| BNP PARIBAS ARBITRAGE - ODIForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | In concert | In concert | In concert | In concert | 1.26% | In concert | In concert | In concert | In concert | In concert | In concert | In concert | 1.37% | In concert | In concert | – | – | – | – | – | – | – | – | – | – | – | – |
| INVESCO PACIFIC FUND (UK)Foreign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.05% | 1.17% | In concert | – | – | – | – | – | – | – | – | – | – | – | – | – |
| SAUDI ARABIAN MONETARY AUTHORITY - EMERGING MARKETInstitutions Foreign Portfolio Investor | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ICICI PRUDENTIAL LIFE INSURANCE COMPANY LIMITEDOther Institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.01% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ABU DHABI INVESTMENT AUTHORITY - BEACONInstitutions Foreign Portfolio Investor | – | – | – | – | – | – | – | – | – | – | – | 1.11% | 1.05% | 1.04% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| AMANSA HOLDINGS PRIVATE LIMITEDInstitutions Foreign Portfolio Investor | – | – | – | – | – | 1.18% | 1.20% | 1.20% | 1.08% | 1.08% | 1.14% | 1.26% | 1.17% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| STICHTING DEPOSITARY APG EMERGING MARKETS EQUITY POOLInstitutions Foreign Portfolio Investor | 1.09% | 1.10% | – | 1.07% | 1.04% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| JHUNJHUNWALA RAKESH RADHESHYAMResident individuals, over ₹2 lakh at face value | – | 1.08% | 1.12% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ABU DHABI INVESTMENT AUTHORITY - BEHAVEInstitutions Foreign Portfolio Investor | 1.31% | 1.02% | – | – | – | – | – | – | – | – | – | In concert | – | In concert | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| RAKESH JHUNJHUNWALAResident individuals, over ₹2 lakh at face value | 1.09% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Who moved in the Sep 2026 filing
Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Indian institutions: NPS TRUST A/C - SBI PENSION FUND - UPS - CG SCHEM newly named at 2.80%; NPS TRUST - A/C SBI PENSION FUND SCHEME - NPS TIER no longer named, from 2.74%; LIFE INSURANCE CORPORATION OF INDIA 2.85%, −0.09 pts
Persons acting in concert
From the filing for Sep 2026.
| NamePersons acting in concert. Shareholders who have agreed to act together in the company, such as members of a family or a fund house and its schemes, listed together in the filing with what each holds. Persons acting in concert in the glossary | Holding | Shares |
|---|---|---|
| QUANT MUTUAL FUND - QUANT ARBITRAGE FUND | 0.01% | 49,500 |
| QUANT MUTUAL FUND - QSIF SECTOR ROTATION LONG - SHORT FUND | 0.00% | 10,948 |
| QUANT MUTUAL FUND - QUANT DYNAMIC ASSET ALLOCATION FUND | 0.09% | 4,96,695 |
| QUANT MUTUAL FUND - QUANT BUSINESS CYCLE FUND | 0.10% | 5,77,381 |
| QUANT MUTUAL FUND - QUANT MANUFACTURING FUND | 0.07% | 4,23,544 |
| QUANT MUTUAL FUND - QUANT HEALTHCARE FUND | 0.02% | 1,29,172 |
| QUANT MUTUAL FUND - QUANT MOMENTUM FUND | 0.12% | 7,08,612 |
| QUANT MUTUAL FUND - QUANT CONSUMPTION FUND | 0.02% | 96,058 |
| QUANT MUTUAL FUND-QUANT ELSS TAX SAVER FUND | 1.16% | 66,52,259 |
| QUANT MUTUAL FUND - QUANT MID CAP FUND | 0.85% | 49,02,846 |
| QUANT MUTUAL FUND - QUANT AGGRESSIVE HYBRID FUND | 0.18% | 10,12,165 |
| QUANT MUTUAL FUND - QUANT MULTI CAP FUND | 0.74% | 42,57,303 |